{{Rsnum
|rsid=16840639
|Gene=LOC100289145
|Chromosome=1
|position=196855643
|Orientation=plus
|GMAF=0.1887
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 7.7 | 33.8 | 58.5
| HCB | 2.2 | 17.8 | 80.0
| JPT | 0.0 | 13.3 | 86.7
| YRI | 25.8 | 46.8 | 27.4
| ASW | 0.0 | 0.0 | 0.0
| CHB | 2.2 | 17.8 | 80.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID|19789632|OA=1
}} We found that YRI have significantly lower copy number of [[CFHR3]] gene (Complement Factor H-Related gene 3) than CEU and ASN individuals. In addition, we have observed that this variant is well tagged by a SNP ([[rs16840639]]; r2 = 0.79)

{{PMID Auto
|PMID=21637784
|Title=Association of genetic variants in complement factor h and factor h-related genes with systemic lupus erythematosus susceptibility
|OA=1
}}

{{PMID Auto
|PMID=23582991
|Title=Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}